Clincosm LogoSign in Get a demo

Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

Sponsor
Bursa Yüksek İhtisas Education and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04805684
Collaborator
(none)
59
Enrollment
1
Location
2
Arms
2.1
Actual Duration (Months)
28.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.

Condition or Disease Intervention/Treatment Phase
  • Device: LUS Twelve area
  • Device: LUS Fourteen area
 N/A

Detailed Description

In our study, we aimed to determine the correlation between lung findings of COVID 19 pneumonia and thoracic tomography with the results of LUS applied to different numbers (12 versus 14) of areas.

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Masking Description:
The investigator was unaware of patient information such as medical history, PCR (polymerase chain reaction) test result, laboratory measurements, and CT scan results
Primary Purpose:
Diagnostic
Official Title:
Comparison of Two Different Lung Ultrasound Imaging Protocols in COVID -19 Pneumonia
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Mar 5, 2021
Actual Study Completion Date :
Mar 5, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: lung ultrasound 12

12 zone lung ultrasonography protocol

Device: LUS Twelve area
Application of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
Active Comparator: lung ultrasound 14

14 zone lung ultrasonography protocol

Device: LUS Fourteen area
Application of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)

Outcome Measures

Primary Outcome Measures

  1. Correlation between Thoracic CT imaging results and LUS results [6 hours]

    Lung ultrasonography will be performed within 6 hours of the Thoracic CT.

Secondary Outcome Measures

  1. Characteristics of lesions [6 hours]

    Identifying the characteristics of the abnormal findings detected in Thoracic CT and LUS

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • 18 and 85 years old

  • Hospitalized in intensive care unit

  • PCR (polymerase chain reaction) tested

  • Thoracic CT applied

Exclusion Criteria:

  • Previous lung operation

  • Thoracic wall disorder

  • Interstitial lung disease

  • Patients who did not consent to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital Bursa Turkey

Sponsors and Collaborators

  • Bursa Yüksek İhtisas Education and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Korgün Ökmen, Principal Investigator ,Assoc. PhD. M.D., Bursa Yüksek İhtisas Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT04805684
Other Study ID Numbers:
  • 2011-KAEK-25 2021
First Posted:
Mar 18, 2021
Last Update Posted:
Mar 18, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
COVID-19
Pneumonia

Study Results

No Results Posted as of Mar 18, 2021